Corrigendum to "Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients". [Int J Antimicrob Agents 51 (2018) 594-600].

Dhaese, Sofie A M; Roberts, Jason A; Carlier, Mieke; Verstraete, Alain G; Stove, Veronique; De Waele, Jan J

Dhaese, Sofie A M; Roberts, Jason A; Carlier, Mieke; Verstraete, Alain G; Stove, Veronique; De Waele, Jan J.

Afiliación

Dhaese SAM; Ghent University Hospital, Intensive Care, Ghent, Belgium. Electronic address: sofie.dhaese@ugent.be.
Roberts JA; Faculty of Medicine and School of Pharmacy, University of Queensland, Brisbane, Australia; Royal Brisbane and Women's Hospital, Brisbane, Australia.
Carlier M; Ghent University Hospital, Laboratory Medicine, Ghent, Belgium.
Verstraete AG; Ghent University Hospital, Laboratory Medicine, Ghent, Belgium; Ghent University, Clinical Chemistry, Microbiology and Immunology, Ghent, Belgium.
Stove V; Ghent University Hospital, Laboratory Medicine, Ghent, Belgium; Ghent University, Clinical Chemistry, Microbiology and Immunology, Ghent, Belgium.
De Waele JJ; Ghent University Hospital, Intensive Care, Ghent, Belgium.

Int J Antimicrob Agents ; 54(3): 380, 2019 Sep.

Article en En | MEDLINE | ID: mdl-31399316

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int J Antimicrob Agents Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google